Diagnosis of measles with an IgM capture EIA: The optimal timing of specimen collection after rash onset

被引:81
作者
Helfand, RF
Heath, JL
Anderson, LJ
Maes, EF
Guris, D
Bellini, WJ
机构
[1] EMORY UNIV,DEPT PEDIAT,ATLANTA,GA 30322
[2] CTR DIS CONTROL & PREVENT,NATL CTR INFECT DIS,DIV VIRAL & RICKETTSIAL DIS,ATLANTA,GA
[3] CTR DIS CONTROL & PREVENT,NATL IMMUNIZATION PROGRAM,EPIDEMIOL & SURVEILLANCE DIV,ATLANTA,GA 30333
[4] CTR DIS CONTROL & PREVENT,EPIDEMIOL & SURVEILLANCE DIV,ATLANTA,GA
关键词
ENZYME IMMUNOASSAYS; VIRUS; ANTIBODIES; TESTS;
D O I
10.1093/infdis/175.1.195
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The optimal timing for collection of a single serum specimen to diagnose measles by using a monoclonal antibody-capture EIA was evaluated. Results of testing paired serum samples from 166 measles cases with at least 1 IgM-positive specimen were analyzed. Among persons whose second samples were IgM-positive, the seropositivity rate for first samples was 77% when collected within 72 h and 100% when collected 4-11 days after rash onset, Among unvaccinated persons whose first samples were IgM-positive, the rate for IgM positivity of second specimens declined from 100% at 4 days to 94% at 4 weeks after rash onset, then declined further to 63% at 5 weeks, Some previously vaccinated persons became IgM-negative during the third week after rash onset, In general, a single serum specimen collected between 72 h and 4 weeks after rash onset can be used to diagnose most cases of measles with an IgM capture EIA.
引用
收藏
页码:195 / 199
页数:5
相关论文
共 15 条
[1]   DETECTION OF IGM ANTIBODIES SPECIFIC FOR MEASLES-VIRUS BY CAPTURE AND INDIRECT ENZYME IMMUNOASSAYS [J].
ARISTA, S ;
FERRARO, D ;
CASCIO, A ;
VIZZI, E ;
DISTEFANO, R .
RESEARCH IN VIROLOGY, 1995, 146 (03) :225-232
[2]  
BELLINI WJ, 1996, DIAGNOSTIC PROCEDURE, P447
[3]   THE CONTRIBUTION OF FIELD-TESTS TO MEASLES SURVEILLANCE AND CONTROL - A REVIEW OF AVAILABLE METHODS [J].
CUTTS, FT ;
BROWN, DWG .
REVIEWS IN MEDICAL VIROLOGY, 1995, 5 (01) :35-40
[4]   Measles elimination in the Americas - Evolving strategies [J].
deQuadros, CA ;
Olive, JM ;
Hersh, BS ;
Strassburg, MA ;
Henderson, DA ;
BrandlingBennett, D ;
Alleyne, GAO .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (03) :224-229
[5]   IMMUNOGLOBULIN-M ANTIBODY-RESPONSE TO MEASLES-VIRUS FOLLOWING PRIMARY AND SECONDARY VACCINATION AND NATURAL VIRUS-INFECTION [J].
ERDMAN, DD ;
HEATH, JL ;
WATSON, JC ;
MARKOWITZ, LE ;
BELLINI, WJ .
JOURNAL OF MEDICAL VIROLOGY, 1993, 41 (01) :44-48
[6]   EVALUATION OF MONOCLONAL ANTIBODY-BASED CAPTURE ENZYME IMMUNOASSAYS FOR DETECTION OF SPECIFIC ANTIBODIES TO MEASLES-VIRUS [J].
ERDMAN, DD ;
ANDERSON, LJ ;
ADAMS, DR ;
STEWART, JA ;
MARKOWITZ, LE ;
BELLINI, WJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (07) :1466-1471
[7]  
GEHAN EA, 1965, BIOMETRIKA, V52, P203, DOI 10.1093/biomet/52.1-2.203
[8]   BACULOVIRUS EXPRESSION OF THE NUCLEOPROTEIN GENE OF MEASLES-VIRUS AND UTILITY OF THE RECOMBINANT PROTEIN IN DIAGNOSTIC ENZYME IMMUNOASSAYS [J].
HUMMEL, KB ;
ERDMAN, DD ;
HEATH, J ;
BELLINI, WJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (11) :2874-2880
[9]   FALSE-POSITIVE RUBEOLA IGM TESTS [J].
JENKERSON, SA ;
BELLER, M ;
MIDDAUGH, JP ;
ERDMAN, DD .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (16) :1103-1104
[10]  
Lehmann E.L., 1975, NONPARAMETRICS